Abstract Introduction: The AGO (Arbeitsgemeinschaft Gynäkologische Onkologie, German
Gynecological Oncology Group) Task Force on Diagnosis and Treatment of Breast Cancer …

Background: Each year the interdisciplinary Arbeitsgemeinschaft Gynäkologische Onkologie
(AGO), German Gynecological Oncology Group Breast Committee on Diagnosis and …

Importance The increasing use of neoadjuvant systemic therapy (NST) has led to substantial
pathological complete response rates in patients with initially node-positive, early breast …

The increased use of neoadjuvant chemotherapy (NACT) has changed the approach to
breast surgery. NACT allows de-escalation of surgery by both increasing breast …

Purpose Neoadjuvant chemotherapy (NACT) is increasingly adopted in the therapy of breast
cancer (BC) patients with positive axillary nodes (cN+), but the reliability and feasibility of …

Background There is no consensus on axillary management after neoadjuvant therapy
(NAT) in patients with clinically node-positive (cN+) breast cancer. To investigate current …

Background: Targeted axillary dissection (TAD) includes biopsy of clipped lymph node and
sentinel lymph nodes. However, clinical evidence regarding clinical feasibility and …

Purpose In clinically node-positive breast cancer patients receiving neoadjuvant systemic
therapy (NST), nodal metastases can be initially marked and then removed during surgical …

Purpose Currently, various techniques are available to mark and selectively remove initially
suspicious axillary lymph nodes (target lymph nodes, TLNs) in breast cancer patients …

Breast cancer is the leading cause of cancer in women in Spain and its annual incidence is
rapidly increasing. Thanks to the screening programs in place, nearly 90% of breast cancer …